| abstract |
A cardiac rhythm management system detects a condition indicative of acute decompensated heart failure and, in response, delivering a drug therapy. The system includes an implantable device communicating with a transdermal drug delivery device. The transdermal drug delivery device delivers a pharmaceutical substance in response to a detection of the condition by the implantable device. In one example, the implantable device detects the condition by monitoring a hemodynamic performance. In another example, the implantable device detects the condition by sensing a signal indicative of decompensation. |